Advertisement

European Journal of Nutrition

, Volume 52, Issue 2, pp 705–715 | Cite as

Glycemic index, glycemic load and endometrial cancer risk: results from the Australian National Endometrial Cancer study and an updated systematic review and meta-analysis

  • Christina M. Nagle
  • Catherine M. Olsen
  • Torukiri I. Ibiebele
  • Amanda B. Spurdle
  • Penelope M. Webb
  • The Australian National Endometrial Cancer Study Group
  • The Australian Ovarian Cancer Study Group
Original Contribution

Abstract

Purpose

The relationship between habitual consumption of foods with a high glycemic index (GI) and/or a diet with a high glycemic load (GL) and risk of endometrial cancer is uncertain, and relatively few studies have investigated these associations. The objectives of this study were to examine the association between GI/GL and risk of endometrial cancer using data from an Australian population-based case–control study and systematically review all the available evidence to quantify the magnitude of the association using meta-analysis.

Methods

The case–control study included 1,290 women aged 18–79 years with newly diagnosed, histologically confirmed endometrial cancer and 1,436 population controls. Controls were selected to match the expected Australian state of residence and age distribution (in 5-year bands) of cases. For the systematic review, relevant studies were identified by searching PubMed and Embase databases through to July 2011. Random-effects models were used to calculate the summary risk estimates, overall and dose–response.

Results

In our case–control study, we observed a modest positive association between high dietary GI (OR 1.43, 95 % CI 1.11–1.83) and risk of endometrial cancer, but no association with high dietary GL (OR 1.15, 95 % CI 0.90–1.48). For the meta-analysis, we collated information from six cohort and two case–control studies, involving a total of 5,569 cases. The pooled OR for the highest versus the lowest intake category of GI was 1.15 (0.95–1.40); however, there was significant heterogeneity (p 0.004) by study design (RR 1.00 [95 % CI 0.87–1.14] for cohort studies and 1.56 [95 % CI 1.21–2.02] for case–control studies). There was no association in the dose–response meta-analysis of GI (RR per 5 unit/day increment of GI 1.00, 95 % CI 0.97–1.03). GL was positively associated with endometrial cancer. The pooled RR for the highest versus the lowest GL intake was 1.21 (95 % CI 1.09–1.33) and 1.06 (95 % CI 1.01–1.11) per 50 unit/day increment of GL in the dose–response meta-analysis.

Conclusion

The pooled results from observational studies, including our case–control results, provide evidence of a modest positive association between high GL, but not GI, and endometrial cancer risk.

Keywords

Glycemic load Glycemic index Case–control Dose–response meta-analysis Endometrial cancer 

Notes

Acknowledgments

We thank all the women who participated in the study. We gratefully acknowledge the cooperation of the following institutions: NSW: John Hunter Hospital, Liverpool Hospital, Mater Misericordiae Hospital (Sydney), Mater Misericordiae Hospital (Newcastle), Newcastle Private Hospital, North Shore Private Hospital, Royal Hospital for Women, Royal Prince Alfred Hospital, Royal North Shore Hospital, Royal Prince Alfred Hospital, St George Hospital; Westmead Hospital, Westmead Private Hospital; Qld: Brisbane Private Hospital, Greenslopes Hospital, Mater Misericordiae Hospitals, Royal Brisbane and Women’s Hospital, Wesley Hospital, Queensland Cancer Registry; SA: Adelaide Pathology Partners, Burnside Hospital, Calvary Hospital, Flinders Medical Centre, Queen Elizabeth Hospital, Royal Adelaide Hospital, South Australian Cancer Registry; Tas: Launceston Hospital, North West Regional Hospitals, Royal Hobart Hospital; Vic: Freemasons Hospital, Melbourne Pathology Services, Mercy Hospital for Women, Royal Women’s Hospital, Victorian Cancer Registry; WA: King Edward Memorial Hospital, St John of God Hospitals Subiaco & Murdoch, Western Australian Cancer Registry. We also thank the authors of previously published studies who contributed information for the dose–response meta-analysis: Xiaohui Cui, Anne Cust, Aaron Folsom and Stephanie George. These analyses were supported by The Cancer Council Queensland [#496680]. The Australian National Endometrial Cancer Study was supported by the National Health and Medical Research Council (NHMRC) of Australia (#339435) and Cancer Council Tasmania (#403031 and 457636). CM Nagle, PM Webb and AB Spurdle are funded by NHMRC Fellowships.

Supplementary material

394_2012_376_MOESM1_ESM.docx (41 kb)
Supplementary material 1 (DOCX 41 kb)

References

  1. 1.
    Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11(12):1531–1543Google Scholar
  2. 2.
    Cust AE, Allen NE, Rinaldi S, Dossus L, Friedenreich C, Olsen A, Tjonneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Linseisen J, Chang-Claude J, Boeing H, Schulz M, Benetou V, Trichopoulou A, Trichopoulos D, Palli D, Berrino F, Tumino R, Mattiello A, Vineis P, Quiros JR, Agudo A, Sanchez MJ, Larranaga N, Navarro C, Ardanaz E, Bueno-de-Mesquita HB, Peeters PH, van Gils CH, Bingham S, Khaw KT, Key T, Slimani N, Riboli E, Kaaks R (2007) Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition. Int J Cancer 120(12):2656–2664. doi: 10.1002/ijc.22578 CrossRefGoogle Scholar
  3. 3.
    Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, Muti P, Lenner P, Koenig KL, Biessy C, Krogh V, Riboli E, Shore RE, Stattin P, Berrino F, Hallmans G, Toniolo P, Kaaks R (2004) Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer 108(2):262–268. doi: 10.1002/ijc.11544 CrossRefGoogle Scholar
  4. 4.
    Becker S, Dossus L, Kaaks R (2009) Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem 115(2):86–96. doi: 10.1080/13813450902878054 CrossRefGoogle Scholar
  5. 5.
    Bjorck I, Granfeldt Y, Liljeberg H, Tovar J, Asp NG (1994) Food properties affecting the digestion and absorption of carbohydrates. Am J Clin Nutr 59(3 Suppl):699S–705SGoogle Scholar
  6. 6.
    Brand-Miller J, McMillan-Price J, Steinbeck K, Caterson I (2009) Dietary glycemic index: health implications. J Am Coll Nutr 28(Suppl):446S–449SGoogle Scholar
  7. 7.
    Ludwig DS (2002) The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 287(18):2414–2423CrossRefGoogle Scholar
  8. 8.
    Augustin LS, Gallus S, Bosetti C, Levi F, Negri E, Franceschi S, Dal Maso L, Jenkins DJ, Kendall CW, La Vecchia C (2003) Glycemic index and glycemic load in endometrial cancer. Int J Cancer 105(3):404–407. doi: 10.1002/ijc.11089 CrossRefGoogle Scholar
  9. 9.
    Silvera SA, Rohan TE, Jain M, Terry PD, Howe GR, Miller AB (2005) Glycaemic index, glycaemic load and risk of endometrial cancer: a prospective cohort study. Public Health Nutr 8(7):912–919CrossRefGoogle Scholar
  10. 10.
    Cui X, Rosner B, Willett WC, Hankinson SE (2011) Dietary fat, fiber, and carbohydrate intake in relation to risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 20(5):978–989CrossRefGoogle Scholar
  11. 11.
    Cust AE, Slimani N, Kaaks R, van Bakel M, Biessy C, Ferrari P, Laville M, Tjonneland A, Olsen A, Overvad K, Lajous M, Clavel-Chapelon F, Boutron-Ruault MC, Linseisen J, Rohrmann S, Nothlings U, Boeing H, Palli D, Sieri S, Panico S, Tumino R, Sacerdote C, Skeie G, Engeset D, Gram IT, Quiros JR, Jakszyn P, Sanchez MJ, Larranaga N, Navarro C, Ardanaz E, Wirfalt E, Berglund G, Lundin E, Hallmans G, Bueno-de-Mesquita HB, Du H, Peeters PH, Bingham S, Khaw KT, Allen NE, Key TJ, Jenab M, Riboli E (2007) Dietary carbohydrates, glycemic index, glycemic load, and endometrial cancer risk within the European prospective investigation into cancer and nutrition cohort. Am J Epidemiol 166(8):912–923CrossRefGoogle Scholar
  12. 12.
    Folsom AR, Demissie Z, Harnack L (2003) Glycemic index, glycemic load, and incidence of endometrial cancer: the Iowa women’s health study. Nutr Cancer 46(2):119–124CrossRefGoogle Scholar
  13. 13.
    George SM, Mayne ST, Leitzmann MF, Park Y, Schatzkin A, Flood A, Hollenbeck A, Subar AF (2009) Dietary glycemic index, glycemic load, and risk of cancer: a prospective cohort study. Am J Epidemiol 169(4):462–472CrossRefGoogle Scholar
  14. 14.
    Larsson SC, Friberg E, Wolk A (2007) Carbohydrate intake, glycemic index and glycemic load in relation to risk of endometrial cancer: a prospective study of Swedish women. Int J Cancer 120(5):1103–1107. doi: 10.1002/ijc.22422 CrossRefGoogle Scholar
  15. 15.
    Gnagnarella P, Gandini S, La Vecchia C, Maisonneuve P (2008) Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am J Clin Nutr 87(6):1793–1801Google Scholar
  16. 16.
    Mulholland HG, Murray LJ, Cardwell CR, Cantwell MM (2008) Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis. Br J Cancer 99(3):434–441CrossRefGoogle Scholar
  17. 17.
    Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P, Brand-Miller JC (2008) Glycemic index, glycemic load, and chronic disease risk–a meta-analysis of observational studies. Am J Clin Nutr 87(3):627–637Google Scholar
  18. 18.
    Mulholland HG, Murray LJ, Cantwell MM (2008) Glycemic index, glycemic load, and chronic disease risk. Am J Clin Nutr 88 (2):475–476; author reply 476–477Google Scholar
  19. 19.
    Rowlands IJ, Nagle CM, Spurdle AB, Webb PM (2011) Gynecological conditions and the risk of endometrial cancer. Gynecol Oncol 123(3):537–541CrossRefGoogle Scholar
  20. 20.
    Merritt MA, Green AC, Nagle CM, Webb PM (2008) Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer 122(1):170–176CrossRefGoogle Scholar
  21. 21.
    Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122(1):51–65Google Scholar
  22. 22.
    McNaughton SA, Marks GC, Gaffney P, Williams G, Green A (2005) Validation of a food-frequency questionnaire assessment of carotenoid and vitamin E intake using weighed food records and plasma biomarkers: the method of triads model. Eur J Clin Nutr 59(2):211–218CrossRefGoogle Scholar
  23. 23.
    Ibiebele TI, Parekh S, Mallitt KA, Hughes MC, O’Rourke PK, Webb PM (2009) Reproducibility of food and nutrient intake estimates using a semi-quantitative FFQ in Australian adults. Public Health Nutr 12(12):2359–2365CrossRefGoogle Scholar
  24. 24.
    Atkinson FS, Foster-Powell K, Brand-Miller JC (2008) International tables of glycemic index and glycemic load values. Diabetes Care 31(12):2281–2283CrossRefGoogle Scholar
  25. 25.
    Silverberg S, Kurman RJ, Nogales F et al (eds) (2003) Tumours of the uterine corpus. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. IRAC Press, LyonGoogle Scholar
  26. 26.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefGoogle Scholar
  27. 27.
    Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11):1301–1309Google Scholar
  28. 28.
    Orsini N, Bellocco R, Greenland S (2006) Generalized least squares for trend estimation of summarized dose-response data. Stata J 6:40–57Google Scholar
  29. 29.
    Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101CrossRefGoogle Scholar
  30. 30.
    Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634CrossRefGoogle Scholar
  31. 31.
    Foster-Powell K, Holt SH, Brand-Miller JC (2002) International table of glycemic index and glycemic load values. Am J Clin Nutr 76(1):5–56Google Scholar
  32. 32.
    Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, Stampfer MJ, Wing AL, Willett WC (1997) Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20(4):545–550CrossRefGoogle Scholar
  33. 33.
    Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC (1997) Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277(6):472–477CrossRefGoogle Scholar
  34. 34.
    Howlett J, Ashwell M (2008) Glycemic response and health: summary of a workshop. Am J Clin Nutr 87(1):212S–216SGoogle Scholar
  35. 35.
    Venn BJ, Green TJ (2007) Glycemic index and glycemic load: measurement issues and their effect on diet-disease relationships. Eur J Clin Nutr 61(Suppl 1):S122–S131CrossRefGoogle Scholar
  36. 36.
    Esfahani A, Wong JM, Mirrahimi A, Srichaikul K, Jenkins DJ, Kendall CW (2009) The glycemic index: physiological significance. J Am Coll Nutr 28(Suppl):439S–445SGoogle Scholar
  37. 37.
    Augustin LS, Franceschi S, Jenkins DJ, Kendall CW, La Vecchia C (2002) Glycemic index in chronic disease: a review. Eur J Clin Nutr 56(11):1049–1071. doi: 10.1038/sj.ejcn.1601454 CrossRefGoogle Scholar
  38. 38.
    Kalli KR, Conover CA (2003) The insulin-like growth factor/insulin system in epithelial ovarian cancer. Front Biosci 8:d714–d722CrossRefGoogle Scholar
  39. 39.
    Lukanova A, Kaaks R (2005) Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 14(1):98–107Google Scholar
  40. 40.
    Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21(3):215–244CrossRefGoogle Scholar
  41. 41.
    Kashima H, Shiozawa T, Miyamoto T, Suzuki A, Uchikawa J, Kurai M, Konishi I (2009) Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E. Endocr Relat Cancer 16(1):113–122CrossRefGoogle Scholar
  42. 42.
    Reynolds RK, Hu C, Baker VV (1998) Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines. Gynecol Oncol 70(2):202–209CrossRefGoogle Scholar
  43. 43.
    Collins A, Duthie S, Ross M (1994) Micronutrients and oxidative stress in the aetiology of cancer. Proc Nutr Soc 53(1):67–75CrossRefGoogle Scholar
  44. 44.
    Jeppesen J, Schaaf P, Jones C, Zhou MY, Chen YD, Reaven GM (1997) Effects of low-fat, high-carbohydrate diets on risk factors for ischemic heart disease in postmenopausal women. Am J Clin Nutr 65(4):1027–1033Google Scholar
  45. 45.
    Marks GC, Hughes MC, van der Pols JC (2006) Relative validity of food intake estimates using a food frequency questionnaire is associated with sex, age, and other personal characteristics. The Journal of nutrition 136(2):459–465Google Scholar
  46. 46.
    Kipnis V, Midthune D, Freedman L, Bingham S, Day NE, Riboli E, Ferrari P, Carroll RJ (2002) Bias in dietary-report instruments and its implications for nutritional epidemiology. Public Health Nutr 5 (6A):915–923. doi: 10.1079/PHN2002383 Google Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Christina M. Nagle
    • 1
  • Catherine M. Olsen
    • 1
  • Torukiri I. Ibiebele
    • 1
  • Amanda B. Spurdle
    • 2
  • Penelope M. Webb
    • 1
  • The Australian National Endometrial Cancer Study Group
    • 1
  • The Australian Ovarian Cancer Study Group
    • 1
  1. 1.Gynaecological Cancers, Population Health Research DepartmentQueensland Institute of Medical ResearchHerston, BrisbaneAustralia
  2. 2.Molecular Cancer Epidemiology, Genetics Research DepartmentQueensland Institute of Medical ResearchHerston, BrisbaneAustralia

Personalised recommendations